Neurology Alert articles from May 2005

Neurology Alert archives from May 2005

Silencing SOD1 for Mutant Huntingtin Through RNA Interference Results in Neuroprotective Effects.
May 1, 2005... Silencing SOD1 for Mutant Huntingtin Through RNA Interference Results in Neuroprotective Effects Abstracts & Commentary Commentary by M. Flint Beal, MD, Professor and Chairman, Department of Neurology, Cornell University Medical...

Narcolepsy - An Autoimmune Disorder?
May 1, 2005... Narcolepsy - An Autoimmune Disorder? Abstracts & Commentary Commentary by Charles P. Pollak Synopsis: IgG from all narcolepsy patients significantly enhanced bladder contractile responses to the muscarinic agonist carbachol and to...

Cluster Headache vs Paroxysmal Hemicrania: A Distinction With a Therapeutic Difference.
May 1, 2005... Cluster Headache vs Paroxysmal Hemicrania: A Distinction With a Therapeutic Difference Abstract & Commentary Commentary by John J. Caronna, Vice-Chairman, Department of Neurology, Cornell University Medical Center, Professor of...

Pregnancy and the Myasthenic.
May 1, 2005... Pregnancy and the Myasthenic Abstract & Commentary Commentary by Michael Rubin, MD, Professor of Clinical Neurology, New York Presbyterian Hospital-Cornell Campus, and Assistant Editor of Neurology Alert. Synopsis: In 15%, and...

Selective Nerve Root Injection.
May 1, 2005... Selective Nerve Root Injection Abstract & Commentary Commentary by Michael Rubin, MD, Professor of Clinical Neurology, New York Presbyterian Hospital-Cornell Campus, and Assistant Editor of Neurology Alert. Synopsis: SNRIs may be...

Rasagiline in Advanced Parkinson's Disease.
May 1, 2005... Rasagiline in Advanced Parkinson's Disease Abstract & Commentary Commentary by Cliffe Henchcliffe Synopsis: Once-daily rasagiline reduces mean daily off-time and improves symptoms of Parkinson's disease in levodopa-treated...

Clinical Briefs in Primary Care Supplement.
May 1, 2005... Click here for the May 2005 Clinical Briefs in Primary Care supplement SOURCE-Neurology Alert

Pharmacology Watch: The FDA Pulls Another COX-2 Inhibitor Off the Market.
May 1, 2005... The FDA Pulls Another COX-2 Inhibitor Off the Market Pharmacology Watch The FDA has asked Pfizer to withdraw valdecoxib (Bextra) from the market due to safety concerns. The request was part of a "Series of Changes to the Class of Marketed...

CME Questions.
May 1, 2005... CME Questions 17. Currently available methods of confirming the diagnosis of narcolepsy do NOT include: a. absent CSF orexin. b. short latencies to sleep onset as well as sleep-onset REM. c. presence of muscarinic...